1. Market Research
  2. > Telecom Market Trends
  3. > United Kingdom Telecommunications Report Q3 2016

United Kingdom Telecommunications Report Q3 2016

  • July 2016
  • -
  • Business Monitor International
  • -
  • 68 pages

Includes 3 FREE quarterly updates

BMI View: The European Commission's refusal to allow 3 and O2 to merge in the UK puts an end toconsolidation efforts in the local market and perhaps other regional European markets for the foreseeablefuture. We believe that consolidation efforts could come to a halt until at least 2019, when a newCommission is set to take charge. Nevertheless, the previous acquisition of EE by BT creates a clear marketleader in the UK telecoms market, offering both fixed and mobile services. This will accelerate thedevelopment of convergence in the country, which has lagged behind its European counterparts.Competition would be boosted by the creation of stronger alternative players, but the deal between 3 andO2 is hitting strong regulatory scrutiny. Furthermore, BT is also under pressure over the future ofOpenreach and whether it is the right mechanism to drive advanced broadband investments.

Latest Updates & Industry Developments

- The European regulator's barring of the proposed 3 and O2 merger will keep the number of majortelecommunications operators at four in the economy. We believe that BT will be leading the market by means of heavy investments into new technologies and will look to regain its top spot in terms of marketshares from O2 in the coming months.

- BMI estimates the UK mobile market ended Q116 with 78.39mn subscribers, a y-o-y growth of just0.9%.

- There were 33.61mn fixed line connections in operation in Q315, with BT having a 38.4% market share.

- There were 29.96mn broadband subscribers in Q315, of which 24.4mn were fixed. Out of those, BT hada 32.3% market share.

Table Of Contents

United Kingdom Telecommunications Report Q3 2016
BMI Industry View 7
SWOT 9
Industry Forecast 10
Latest Updates 10
Structural Trends 10
Wireline Voice and Broadband 13
Table: Telecoms Sector - Historical Data and Forecasts (United Kingdom 2013-2020) 14
Industry Risk/Reward Index 16
Western Europe Risk/Reward Index 16
Table: Western Europe Risk/Reward Index, Q3 2016 18
United Kingdom Risk/Reward Index 19
Market Overview 21
Market Drivers and Trends 21
Mobile 23
Wireline Voice and Broadband 26
Pay TV/Convergence 29
Regulatory Development 31
Regulatory Overview 31
Table: Division Of Regulatory Responsibilities In The UK 31
Regulatory Developments 33
Table: Detailed Outline of 800MHz And 2,600MHz Spectrum Licences 36
Competitive Landscape 37
Table: Key Players - Telecoms Sector 37
Table: Mobile Market Overview 37
Operator Data 38
Table: O2 38
Table: Vodafone 39
Table: EE 40
Table: 3 42
Company Profile 44
BT 44
EE 48
O2 51
Vodafone 54
Demographic Forecast 57
Table: Population Headline Indicators (United Kingdom 1990-2025) 58
Table: Key Population Ratios (United Kingdom 1990-2025) 58
Table: Urban/Rural Population and Life Expectancy (United Kingdom 1990-2025) 59
Table: Population By Age Group (United Kingdom 1990-2025) 59
Table: Population By Age Group % (United Kingdom 1990-2025) 60
Glossary 62
Table: Glossary Of Terms 62
Methodology 64
Industry Forecast Methodology 64
Sources 66
Risk/Reward Index Methodology 66
Table: Risk/Reward Index Indicators 67
Table: Weighting Of Indicators 68

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Cancer Immunotherapy: Analytical Tool

Cancer Immunotherapy: Analytical Tool

  • $ 13 125
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Deals & Alliances in Oncology Drug Development: Analytical Tool

Deals & Alliances in Oncology Drug Development: Analytical Tool

  • $ 13 125
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Combination Therapy Drugs in Oncology: Analytical Tool

Combination Therapy Drugs in Oncology: Analytical Tool

  • $ 13 125
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Cancer At Bio: Analytical Tool

August 2016 $ 13 125

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.